Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
addressed, aiming, alive, answer, argument, binding, bottleneck, breadth, cadence, causation, centerpiece, clone, CMC, compromise, Consul, correction, corrective, culmination, customer, de, deployed, depth, disaggregated, disaggregation, disruption, dissatisfaction, distinct, drawn, Dunn, engineering, exhausted, extortion, facilitate, franchise, futile, FVO, gave, Gibson, half, hundred, immunogenic, immunotherapy, incident, incorrect, interruption, Judge, jurisdiction, Liau, MAA, machine, Magistrate, MIA, mid, midst, MoA, mock, Neurosurgery, nutritional, older, operationally, oral, outlined, PD, penetration, peptide, plead, posture, prejudice, prepayment, privacy, prototype, published, purity, pursuit, ransom, real, reconciliation, regressed, replead, SAB, scrutiny, spite, surgery, theft, threat, TMF, transparency, UCLA, unaudited, version, world
Removed:
advance, allocated, announcement, assigned, auditing, BCF, bore, combined, Corning, correspondingly, COVID, deducting, disability, efficiency, employment, flexibility, forbearance, functioning, implementation, installed, integral, intended, intrinsic, invoiced, involvement, joined, leave, loaned, location, lock, originally, overdue, pandemic, payroll, purpose, query, ratably, reassigned, removing, rent, Replacement, retrospective, seller, separation, Simplifying, social, Steering, storing, subjected, successive, suspended, suspending, unamortized, unavailable, undergone, wrote
Filing tables
Filing exhibits
NWBO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333-267933) of our report dated March 5, 2024, with respect to our audits of the consolidated financial statements of Northwest Biotherapeutics, Inc. (the “Company”), and the effectiveness of the Company’s internal control over financial reporting, appearing in the Annual Report on Form 10-K as of and for the year ended December 31, 2023, and to reference to us under the heading “Experts” in such registration statement.
/s/ Cherry Bekaert LLP
Tampa, Florida
March 5, 2024